Islet Management’s Medicines Co MDCO Stock Holding History

Islet Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-65,000	Closed	-$3.25M	–	137
2019 Q3	$3.25M	Buy	65,000 +55,000	+550%	+$2.19M	0.41%	47
2019 Q2	$365K	Buy	+10,000	New	+$326K	0.04%	84

Other funds holding MDCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Islet Management's MDCO Position: Q4 2019 in Review

Islet Management sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 65,000 shares — an estimated $3.25M sold.

Islet Management first reported a position in MDCO in Q2 2019 and held it in 2 quarters. The position peaked at $3.25M in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

Islet Management reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
Islet Management sold 65,000 Medicines Co shares in Q4 2019, an estimated $3.25M.
Islet Management first reported a position in Medicines Co in Q2 2019 and held it in 2 quarters.
Islet Management's Medicines Co position peaked at $3.25M in Q3 2019.
284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Islet Management's 13F filing for Q4 2019, filed 14 Feb 2020.